Maze (IPO)
Funding Details
- Awarder
- Inbox
- Date Award
- May 19, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $131,000,000
Company Info
- Company Description
- Maze is focused on developing innovative treatments for kidney disease, leveraging advanced biotechnology to improve patient outcomes.
- Market
- Kidney Disease